{"id":251388,"date":"2021-11-03T00:00:00","date_gmt":"2021-11-03T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidim0088-biopharma-irritable-bowel-syndrome-epidemiology-europe\/"},"modified":"2026-03-31T10:42:05","modified_gmt":"2026-03-31T10:42:05","slug":"epidim0088-biopharma-irritable-bowel-syndrome-epidemiology-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidim0088-biopharma-irritable-bowel-syndrome-epidemiology-europe\/","title":{"rendered":"Irritable Bowel Syndrome &#8211; Epidemiology &#8211; Europe"},"content":{"rendered":"<p>Clarivate Epidemiology&#8217;s coverage of <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"2\" data-last-change-time=\"1642000955448\" data-time=\"1642000954084\" data-userid=\"3375\" data-username=\"Sarah\"><abbr title=\"irritable bowel syndrome\">IBS<\/abbr> <\/span>comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"7\" data-last-change-time=\"1642000960362\" data-time=\"1642000959445\" data-userid=\"3375\" data-username=\"Sarah\"><abbr title=\"irritable bowel syndrome\">IBS<\/abbr> <\/span>for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe and Japan, and 10 years for the other countries covered in this report.<\/p>\n<p>Clarivate Epidemiology&#8217;s <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"12\" data-last-change-time=\"1642000965554\" data-time=\"1642000964753\" data-userid=\"3375\" data-username=\"Sarah\"><abbr title=\"irritable bowel syndrome\">IBS<\/abbr> <\/span>forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"17\" data-last-change-time=\"1642000970376\" data-time=\"1642000969630\" data-userid=\"3375\" data-username=\"Sarah\"><abbr title=\"irritable bowel syndrome\">IBS<\/abbr> <\/span>over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"28\" data-last-change-time=\"1642000985165\" data-time=\"1642000985165\" data-userid=\"3375\" data-username=\"Sarah\"><span class=\"abbreviation-guard\">MS<\/span><\/span> Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>In total, Clarivate Epidemiology forecasts four <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"22\" data-last-change-time=\"1642000975508\" data-time=\"1642000974715\" data-userid=\"3375\" data-username=\"Sarah\"><abbr title=\"irritable bowel syndrome\">IBS<\/abbr> <\/span>patient populations, as follows:<\/p>\n<ul class=\"round-bullets\">\n<li>Total prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"27\" data-last-change-time=\"1642000979406\" data-time=\"1642000979406\" data-userid=\"3375\" data-username=\"Sarah\">.<\/span><\/li>\n<li>Constipation<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"30\" data-last-change-time=\"1642000997442\" data-time=\"1642000997442\" data-userid=\"3375\" data-username=\"Sarah\">&#8211;<\/span>predominant prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"33\" data-last-change-time=\"1642001042396\" data-time=\"1642001042396\" data-userid=\"3375\" data-username=\"Sarah\"> (<abbr title=\"constipation-predominant irritable bowel syndrome\">IBS-C<\/abbr>).<\/span><\/li>\n<li>Diarrhea<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"32\" data-last-change-time=\"1642001000857\" data-time=\"1642001000857\" data-userid=\"3375\" data-username=\"Sarah\">&#8211;<\/span>predominant prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"34\" data-last-change-time=\"1642001052796\" data-time=\"1642001052796\" data-userid=\"3375\" data-username=\"Sarah\"> (<abbr title=\"diarrhea-predominant irritable bowel syndrome\">IBS-D<\/abbr>).<\/span><\/li>\n<li>Mixed prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"35\" data-last-change-time=\"1642001062712\" data-time=\"1642001062712\" data-userid=\"3375\" data-username=\"Sarah\"> (<span>IBS-M or IBS-A<\/span>).<\/span><\/li>\n<\/ul>\n<p>Note: <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"37\" data-last-change-time=\"1642001066556\" data-time=\"1642001066556\" data-userid=\"3375\" data-username=\"Sarah\">C<\/span>overage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-251388","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-gastrointestinal","biopharma-therapy-areas-irritable-bowel-syndrome","biopharma-product-epidemiology","biopharma-geography-europe","biopharma-date-950"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251388\/revisions"}],"predecessor-version":[{"id":283823,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251388\/revisions\/283823"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}